MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517070805 A) filed by Adamed Pharma S. A., Czosnow, Poland, on July 25, for 'pharmaceutical composition comprising cytisine.'
Inventor(s) include Lysiak, Magdalena; Zarzycka, Mariola; and Rzasa, Joanna.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a stabilized composition with significantly improved shelf-life stability. More particularly, the present invention relates to a stable liquid aqueous pharmaceutical composition comprising cytisine or a pharmaceutically acceptable salt thereof, at least one antioxidant selected from the group consisting of a sulfite, bisulfite, and metabisulfite compound. The present invention relates also to a use of at least one antioxidant selected from the group consisting of a sulfite, bisulfite, and metabisulfite compound for the stabilization of a liquid aqueous pharmaceutical composition comprising cytisine."
The patent application was internationally filed on Feb. 22, 2024, under International application No.PCT/EP2024/054519.
Disclaimer: Curated by HT Syndication.
